PHAXIAM Therapeutics S.A. (PHXM) — Cash Flow Reinvestment Rate
Latest as of December 2012:
0.08x
PHAXIAM Therapeutics S.A. (PHXM) has a Cash Flow Reinvestment Rate of 0.08x as of December 2012, reinvesting €48.40K (capex €48.40K ) from operating cash flow of €621.40K. See PHXM FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.08x
(Capex + Investments) / Operating CF
Total Reinvested
€48.40K
Capex + Investments
Operating Cash Flow
€621.40K
EUR
Capital Expenditures
€48.40K
EUR
PHAXIAM Therapeutics S.A. Cash Flow Reinvestment Rate (2012–2012)
Historical reinvestment intensity for PHAXIAM Therapeutics S.A. across 1 annual periods. For the full cash flow conversion analysis, see PHXM cash flow conversion.
Annual Cash Flow Reinvestment Rate for PHAXIAM Therapeutics S.A. (2012–2012)
Year-by-year capital reinvestment analysis for PHAXIAM Therapeutics S.A.. See PHXM financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2012 | 0.08x | €52.50K | €621.40K | €52.50K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow